4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3,4:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[34:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Patent Number 11753419

US 11753419 B2
Application Number17757212
Publication NumberUS 20230021717 A1
Pendency2 years, 9 months, 6 days
Filled DateDec 10, 2020
Priority DateDec 11, 2019
Publication DateJan 26, 2023
Expiration DateDec 10, 2039
Inventor/ApplicantsRobert E Davis
Robert E DAVIS
Kimberly Vanover
Peng LI
Peng Li
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Module Locked
International
2
A61K
C07D
National
0
Field of Search
0
Patent Claims data is locked.
Login To View
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.